EMD Serono, USA
Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany

As One for Patients

At EMD Serono, we recognized the potential of specialty pharmaceuticals and patient care long ago, and have been dedicated to delivering on their promise ever since.

In addition to producing medicines for hard-to-treat conditions, we have a legacy of developing patient assistance programs that help ensure that those who need our therapies are able to access them.

As one of the top five U.S. companies exclusively focused on specialty care, we see our innovation as a matter of balancing science with emotion – integrating our top minds in research and development with the insights from patients and health care practitioners confronting real-world concerns.
ABOUT EMD SERONO
ABOUT EMD SERONO
While our company history goes back to 17th century Germany, our global organization today thrives on innovative and passionate employees who are dedicated to serving our patients.

Fernando, Head, US Medical Affairs, Neurodegenerative Diseases

Introspective Solution Seeker

To me, problems are a blessing. I am most creative, more challenged, and more myself when I am trying to solve a new problem. I love solving problems.

That’s why I went into medicine. I always say, “This is not going to happen under my watch and this is what we are going to do to keep things under control. We’re going to make the best out of this situation.  We’re going to identify what the gaps are, what led to this situation, and we’re going to make sure that this doesn’t happen again."

The fact that my daughter survived what doctors thought was terminal cancer, has helped me see the world from a very different perspective.

If you are persistent, if you approach every project with a vision, with perseverance, with vigor, with energy, and you don’t let go, but keep at it, you’ll eventually get there.  So when I mentally visualize that I can obtain something, it’s already a reality.

That's the mindset that I need to bring to work everyday, looking for solutions to the challenges that patients with relapsing Multiple Sclerosis face.

SERVICES